Journal of Experimental Medicine, Vol 176, 667-677, Copyright © 1992 by Rockefeller University Press

ARTICLES

Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: more than blocking alone

MH Wauben, CJ Boog, R van der Zee, I Joosten, A Schlief and W van Eden
Institute of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, University of Utrecht, The Netherlands.

Peptide analogues of disease-associated epitopes were studied for inhibition of experimental allergic encephalomyelitis (EAE) and adjuvant arthritis (AA) in Lewis rats. EAE- and AA-associated analogues were selected as competitors because of their in vitro inhibitory activity on proliferation of encephalitogenic and arthritogenic T cells. Although the EAE-associated competitor had a superior major histocompatibility complex (MHC) binding affinity, the AA-associated competitor was a better inhibitor of the in vitro proliferation of arthritogenic T cells. Furthermore, although in vivo EAE was inhibited by both competitors, AA was only inhibited by the AA-associated competitor. Remarkably, in contrast to what was expected of a regular MHC competitor peptide, the AA-associated peptide analogue also prevented AA upon immunization before disease induction and appeared to induce T cell responses that crossreacted with the original disease- associated epitope. Therefore, it is concluded that antigen-specific regulatory mechanisms were involved in synergy with MHC competition. The integration of both qualities into a single "competitor-modulator" analogue peptide may lead to the development of novel, more effective, disease-specific immunomodulatory peptides.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• de Graaf, K. L., Barth, S., Herrmann, M. M., Storch, M. K., Otto, C., Olsson, T., Melms, A., Jung, G., Wiesmuller, K.-H., Weissert, R. (2004). MHC Class II Isotype- and Allele-Specific Attenuation of Experimental Autoimmune Encephalomyelitis. J. Immunol. 173: 2792-2802 [Abstract] [Full Text]  
• van Bilsen, J. H. M., Wagenaar-Hilbers, J. P. A., Grosfeld-Stulemeijer, M. C. J. T., van der Cammen, M. J. F., van Dijk, M. E. A., van Eden, W., Wauben, M. H. M. (2004). Matrix Metalloproteinases as Targets for the Immune System during Experimental Arthritis. J. Immunol. 172: 5063-5068 [Abstract] [Full Text]  
• Hartemann-Heurtier, A., Mars, L. T., Bercovici, N., Desbois, S., Cambouris, C., Piaggio, E., Zappulla, J., Saoudi, A., Liblau, R. S. (2004). An Altered Self-Peptide with Superagonist Activity Blocks a CD8-Mediated Mouse Model of Type 1 Diabetes. J. Immunol. 172: 915-922 [Abstract] [Full Text]  
• den Haan, J. M. M., Mutis, T., Blokland, E., IJzerman, A. P., Goulmy, E. (2002). General T-cell receptor antagonists to immunomodulate HLA-A2-restricted minor histocompatibility antigen HA-1-specific T-cell responses. Blood 99: 985-992 [Abstract] [Full Text]  
• Lenz, D. C., Lu, L., Conant, S. B., Wolf, N. A., Gerard, H. C., Whittum-Hudson, J. A., Hudson, A. P., Swanborg, R. H. (2001). A Chlamydia pneumoniae-Specific Peptide Induces Experimental Autoimmune Encephalomyelitis in Rats. J. Immunol. 167: 1803-1808 [Abstract] [Full Text]  
• Hernandez, H. J., Stadecker, M. J. (1999). Elucidation and Role of Critical Residues of Immunodominant Peptide Associated with T Cell-Mediated Parasitic Disease. J. Immunol. 163: 3877-3882 [Abstract] [Full Text]  
• Taams, L. S., van Eden, W., Wauben, M. H. M. (1999). Dose-Dependent Induction of Distinct Anergic Phenotypes: Multiple Levels of T Cell Anergy. J. Immunol. 162: 1974-1981 [Abstract] [Full Text]  
• Burrows, S. R., Khanna, R., Moss, D. J. (1999). Direct Alloreactivity by Human Cytotoxic T Lymphocytes Can Be Inhibited by Altered Peptide Ligand Antagonism. Blood 93: 1020-1024 [Abstract] [Full Text]  
• Smeltz, R. B., Wauben, M. H. M., Wolf, N. A., Swanborg, R. H. (1999). Critical Requirement for Aspartic Acid at Position 82 of Myelin Basic Protein 73-86 for Recruitment of V{beta}8.2+ T Cells and Encephalitogenicity in the Lewis Rat. J. Immunol. 162: 829-836 [Abstract] [Full Text]  
• Myers, L. K., Tang, B., Rosloniec, E. F., Stuart, J. M., Chiang, T. M., Kang, A. H. (1998). Characterization of a Peptide Analog of a Determinant of Type II Collagen That Suppresses Collagen-Induced Arthritis. J. Immunol. 161: 3589-3595 [Abstract] [Full Text]  
• Soares, L. R. B., Orr, P. L., Garovoy, M. R., Benichou, G. (1998). Differential Activation of T Cells by Natural Antigen Peptide Analogues: Influence on Autoimmune and Alloimmune In Vivo T Cell Responses. J. Immunol. 160: 4768-4775 [Abstract] [Full Text]  
• Daniel, C., Grakoui, A., Allen, P. M. (1998). Inhibition of an In Vitro CD4+ T Cell Alloresponse Using Altered Peptide Ligands. J. Immunol. 160: 3244-3250 [Abstract] [Full Text]  
• Nicholson, L. B., Waldner, H., Carrizosa, A. M., Sette, A., Collins, M., Kuchroo, V. K. (1998). Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptides: Implications for autoimmunity. Proc. Natl. Acad. Sci. USA 95: 264-269 [Abstract] [Full Text]  
• Nicholson, L. B., Murtaza, A., Hafler, B. P., Sette, A., Kuchroo, V. K. (1997). A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens. Proc. Natl. Acad. Sci. USA 94: 9279-9284 [Abstract] [Full Text]  
• Nielsen, P. R., Ellgaard, L., Etzerodt, M., Thogersen, H. C., Poulsen, F. M. (1997). The solution structure of the N-terminal domain of alpha 2-macroglobulin receptor-associated protein. Proc. Natl. Acad. Sci. USA 94: 7521-7525 [Abstract] [Full Text]  
• Katz-Levy, Y., Paas-Rozner, M., Kirshner, S., Dayan, M., Zisman, E., Fridkin, M., Wirguin, I., Sela, M., Mozes, E. (1997). A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses. Proc. Natl. Acad. Sci. USA 94: 3200-3205 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS